ArticleInsights into imaging2011
The future of hybrid imaging-part 3: PET/MR, small-animal imaging and beyond.
Article in Insights into imaging, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 54 citations in OpenAlex.
- Nuclear Cardiac Imaging in the Interventional Suite.Current cardiology reports · 2022Review
- Life is not black and white, nor just Shades of Gray.European journal of nuclear medicine and molecular imaging · 2018Article
- Performance evaluation of the Biograph mCT Flow PET/CT system according to the NEMA NU2-2012 standard.EJNMMI physics · 2015Article
- In vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probe.Circulation. Cardiovascular imaging · 2014Article
- Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer.European journal of nuclear medicine and molecular imaging · 2014Article
- Preclinical imaging: an essential ally in modern biosciences.Molecular diagnosis & therapy · 2014Review
- Does the novel integrated PET/MRI offer the same diagnostic performance as PET/CT for oncological indications?PloS one · 2014Article
- Comparison of standardized uptake values in normal structures between PET/CT and PET/MRI in an oncology patient population.Molecular imaging and biology · 2013Article
- Summary report of the First International Workshop on PET/MR imaging, March 19-23, 2012, Tübingen, Germany.Molecular imaging and biology · 2013Article
- PET/MR imaging of the pelvis in the presence of endoprostheses: reducing image artifacts and increasing accuracy through inpainting.European journal of nuclear medicine and molecular imaging · 2013Article
- Fibrin-targeted PET probes for the detection of thrombi.Molecular pharmaceutics · 2013Article
- MR/PET or PET/MRI: does it matter?Magma (New York, N.Y.) · 2013Article
- Does PET/MR in human brain imaging provide optimal co-registration? A critical reflection.Magma (New York, N.Y.) · 2013Review
- Image artifacts from MR-based attenuation correction in clinical, whole-body PET/MRI.Magma (New York, N.Y.) · 2013Article
- PET-MR imaging using a tri-modality PET/CT-MR system with a dedicated shuttle in clinical routine.Magma (New York, N.Y.) · 2013Review
- Discrete bimodal probes for thrombus imaging.Journal of the American Chemical Society · 2012Article
- The Conundrum of PET/MR.World journal of nuclear medicine · 2012Article
- A Comparison ofIn vivo (Athens, Greece)Article
- Preclinical studies and prospective clinical applications for bacteria-targeted imaging: the future is bright.Clinical and translational imagingReview
Corrections and comments
- Erratum issued
Authors and funding
4 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since the 1990s, hybrid imaging by means of software and hardware image fusion alike allows the intrinsic combination of functional and anatomical image information. This review summarises in three parts the state of the art of dual-technique imaging with a focus on clinical applications. We will attempt to highlight selected areas of potential improvement of combined imaging technologies and new applications. In this third part, we discuss briefly the origins of combined positron emission tomography (PET)/magnetic resonance imaging (MRI). Unlike PET/computed tomography (CT), PET/MRI started out from developments in small-animal imaging technology, and, therefore, we add a section on advances in dual- and multi-modality imaging technology for small animals. Finally, we highlight a number of important aspects beyond technology that should be addressed for a sustained future of hybrid imaging. In short, we predict that, within 10 years, we may see all existing multi-modality imaging systems in clinical routine, including PET/MRI. Despite the current lack of clinical evidence, integrated PET/MRI may become particularly important and clinically useful in improved therapy planning for neurodegenerative diseases and subsequent response assessment, as well as in complementary loco-regional oncology imaging. Although desirable, other combinations of imaging systems, such as single-photon emission computed tomography (SPECT)/MRI may be anticipated, but will first need to go through the process of viable clinical prototyping. In the interim, a combination of PET and ultrasound may become available. As exciting as these new possible triple-technique-imaging systems sound, we need to be aware that they have to be technologically feasible, applicable in clinical routine and cost-effective.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.